PPC
CVS icon

Pennington Partners & Co’s CVS Health CVS Stock Holding History

Pennington Partners & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
+2,696
New +$241K 0.09% 105

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Pennington Partners & Co's CVS Position: Q2 2026 in Review

Pennington Partners & Co opened a new position in CVS Health (CVS) in Q2 2026: 2,696 shares worth $279K. The stake represents 0.09% of the portfolio and ranks #105 among its holdings.

2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Pennington Partners & Co held 2,696 shares of CVS Health worth $279K as of Q2 2026.
  • CVS Health was a new Pennington Partners & Co position in Q2 2026.
  • CVS Health made up 0.09% of Pennington Partners & Co's portfolio in Q2 2026, its #105 holding.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Pennington Partners & Co's 13F filing for Q2 2026, filed 14 Aug 2026.